Yardley, D., Brufsky, A., Coleman, R., Conte, P., Cortes, J., Glück, S., Nabholtz, J., O'Shaughnessy, J., Beck, R., Ko, A., Renschler, M., Barton, D., & Harbeck, N. (2016). erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial. Trials, 17(1), 1. http://access.bl.uk/ark:/81055/vdc_100080429382.0x00006f